Beneficient
Beneficient
- Market cap
- $1.00M
Your view on BENFW
Overview
What the company does, where it operates, and who runs it.
About Beneficient
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- James G. Silk
- Headquarters
- 325 North Saint Paul Street, Dallas, TX, US
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- James G. Silk
- Headquarters
- 325 North Saint Paul Street, Dallas, TX, US
Beneficient is a Dallas, Texas-based financial technology company specializing in providing innovative liquidity solutions, alongside extensive trustee, custody, and trust administrative services. Its primary focus is supporting participants within the U.S. alternative asset industry.
The company structures its operations through distinct segments: Ben Liquidity, Ben Custody, and Customer ExAlt Trusts. A cornerstone of its service delivery is the Ben AltAccess platform, a secure online portal enabling end-to-end management of all Beneficient's offerings.
This platform facilitates document uploads, task progression, and transaction completion via standardized agreements.
Beneficient's comprehensive suite of services includes Ben Liquidity, offering financing products for alternative assets; Ben Custody, providing custodial and trust administration for trustees and document custodian services for clients; and Ben Markets, which covers broker-dealer and transfer agency operations.
Additionally, it offers Ben Insurance Services for insurance products and Ben Data for sophisticated data collection, evaluation, and analytics. The company serves a broad spectrum of clients, including individual and institutional investors, wealth advisors, and general partners.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Beneficient. Starting points for Beneficient: EPS -$22.25, beta -0.72 — an Asset Management name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Beneficient. Trailing twelve-month EPS for Beneficient stands at -$22.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | $0.19 | $0.23 | $0.11 | $0.00 |
| Lowest estimate | $0.19 | $0.23 | $0.11 | $0.00 |
| Highest estimate | $0.19 | $0.23 | $0.11 | $0.00 |
| Number of analysts | 1 | 1 | 1 | 0 |
| A year ago | $0.041 | −$12.001 | −$14.181 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | $13.54M | $14.08M | $52.17M | $48.59M |
| Lowest estimate | $13.54M | $14.08M | $52.17M | $48.59M |
| Highest estimate | $13.54M | $14.08M | $52.17M | $48.59M |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | $198000.00 | $49000.00 | −$39.13M | — |
| Growth vs a year ago | +6739.9% | +28632.7% | +233.3% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Beneficient. Beneficient has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| CHARRCharlton Aria Acquisition Corporation | Financial Services | Shell Companies | $1.7M | ||
| CLDICalidi Biotherapeutics, Inc. | Healthcare | Biotechnology | $1.6M | ||
| CWDCaliberCos Inc. | Financial Services | Asset Management | $3.7M | ||
| FUSEWFusemachines Inc. Warrants | Technology | Software - Application | $86,480 | ||
| MKLYRMcKinley Acquisition Corporation Rights | Financial Services | Shell Companies | $3.7M | ||
| ORIQWOrigin Investment Corp I Warrant. | Financial Services | Shell Companies | $1.1M | ||
| PGACPantages Capital Acquisition Corp | Financial Services | Shell Companies | $120.1M | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| NWL.AXNetwealth Group Limited | Financial Services | ASX | — | ||
| OBDCBlue Owl Capital Corporation | Financial Services | NYSE | $5.2B | ||
| OBL.AXOmni Bridgeway Limited | Financial Services | ASX | — | ||
| OCCINOFS Credit Company, Inc. | Financial Services | NASDAQ | $683.6M | ||
| OCSLOaktree Specialty Lending Corporation | Financial Services | NASDAQ | $1.0B | ||
| OFSOFS Capital Corporation | Financial Services | NASDAQ | $44.7M | ||
| OFSSHOFS Capital Corporation 4.95% Notes due 2028 | Financial Services | NASDAQ | $45.8M | ||
| OFSTFCarbon Streaming Corporation | Financial Services | OTC | $32.5M | ||
| OLYFFOlympia Financial Group Inc. | Financial Services | PNK | — | ||
| ONEX.TOOnex Corporation | Financial Services | TSX | $8.6B | ||
| ONEXFOnex Corporation | Financial Services | OTC | $5.2B | ||
| ORLCFOracle Commodity Holding Corp. | Financial Services | OTC | $4.7M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Beneficient, and how their positions are changing. At a $1.0M market value, institutional positions materially move Beneficient's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Beneficient executives and directors. Shares of Beneficient have traded between $0.0091 and $0.01 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Beneficient. Coverage tracks Beneficient within Asset Management (Financial Services). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Beneficient.